PTC Therapeutics Inc (NASDAQ:PTCT)

71.33
Delayed Data
As of Feb 27
 -2.13 / -2.90%
Today’s Change
14.51
Today|||52-Week Range
75.94
+37.78%
Year-to-Date

Today’s Trading

Previous close73.46
Today’s open70.50
Day’s range69.76 - 75.94
Volume1,028,708
Average volume (3 months)478,948
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-155.11%
Earnings growth (this year)+36.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+2.21%
P/E ratioNM
Price/Sales--
Price/Book12.43

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc-0.89-2.55%
HZNPHorizon Pharma PLC+1.46+7.66%
--Cosmo Pharmaceutical...+9.35+6.24%
LCILannett Company Inc-2.77-4.25%
Data as of 4:02pm ET, 02/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.92
Annual revenue (last year)$34.7M
Annual profit (last year)-$48.2M
Net profit margin-138.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Financial Officer
Shane William Charles Kovacs
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account